Literature DB >> 35260989

A Systematic Review of Inflammatory Cytokine Changes Following Aneurysmal Subarachnoid Hemorrhage in Animal Models and Humans.

Patrick Devlin1,2, Tauheed Ishrat1,2,3, Ansley Grimes Stanfill4,5.   

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a severe form of stroke that occurs following rupture of a cerebral aneurysm. Acute inflammation and secondary delayed inflammatory responses, both largely controlled by cytokines, work together to create high mortality and morbidity for this group. The trajectory and time course of cytokine change must be better understood in order to effectively manage unregulated inflammation and improve patient outcomes following aSAH. A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Three different search phrases ("cytokines and subarachnoid hemorrhage," "cytokine levels and subarachnoid hemorrhage," and "cytokine measurement and subarachnoid hemorrhage") were applied across three databases (PubMed, SCOPUS, and the Cochrane Library). Our procedures returned 856 papers. After application of inclusion/exclusion criteria, 95 preclinical animal studies and 41 clinical studies remained. Across studies, 22 different cytokines had been investigated, 5 different tissue types were analyzed, and 3 animal models were utilized. Three main pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) demonstrated reliable increases following aSAH across the included studies. While this is a promising area of research for potential therapeutics, there are gaps in the knowledge base that bar progress for clinical translation of this information. In particular, there is a need for investigations that explore the systemic inflammatory response following injury in a more diverse number of cytokines, the balance of specific pro-/anti- inflammatory cytokines, and how these biomarkers relate to patient outcomes and recovery over time.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Animal model; Cytokines; Inflammation; Patient; Subarachnoid hemorrhage

Year:  2022        PMID: 35260989     DOI: 10.1007/s12975-022-01001-y

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  95 in total

Review 1.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

Review 2.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.

Authors:  Jasper H van Lieshout; Maxine Dibué-Adjei; Jan F Cornelius; Philipp J Slotty; Toni Schneider; Tanja Restin; Hieronymus D Boogaarts; Hans-Jakob Steiger; Athanasios K Petridis; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2017-02-18       Impact factor: 3.042

Review 3.  An Evidence-Based Approach To Diagnosis And Management Of Subarachnoid Hemorrhage In The Emergency Department.

Authors:  Imoigele Aisiku; Jonathan A Edlow; Joshua Goldstein; Lisa E Thomas
Journal:  Emerg Med Pract       Date:  2014-10-01

4.  Aneurysmal subarachnoid hemorrhage lead to systemic upregulation of IL-23/IL-17 inflammatory axis.

Authors:  Shafqat Rasul Chaudhry; Erdem Güresir; Hartmut Vatter; Thomas M Kinfe; Dirk Dietrich; Alf Lamprecht; Sajjad Muhammad
Journal:  Cytokine       Date:  2017-06-10       Impact factor: 3.861

5.  IL-33 expression in the cerebral cortex following experimental subarachnoid hemorrhage in rats.

Authors:  Li-Tian Huang; Hua Li; Qing Sun; Ming Liu; Wei-De Li; Song Li; Zhuang Yu; Wu-Ting Wei; Chun-Hua Hang
Journal:  Cell Mol Neurobiol       Date:  2014-11-23       Impact factor: 5.046

Review 6.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

Authors:  Valery L Feigin; Carlene M M Lawes; Derrick A Bennett; Craig S Anderson
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

7.  Increased serum interleukin-33 concentrations predict worse prognosis of aneurysmal subarachnoid hemorrhage.

Authors:  Jiangbiao Gong; Yu Zhu; Jianbo Yu; Jing Jin; Mantao Chen; Wenchao Liu; Renya Zhan
Journal:  Clin Chim Acta       Date:  2018-08-10       Impact factor: 3.786

Review 8.  Aneurysmal Subarachnoid Hemorrhage.

Authors:  Stanlies D'Souza
Journal:  J Neurosurg Anesthesiol       Date:  2015-07       Impact factor: 3.956

9.  Subarachnoid hemorrhage: who dies, and why?

Authors:  Hector Lantigua; Santiago Ortega-Gutierrez; J Michael Schmidt; Kiwon Lee; Neeraj Badjatia; Sachin Agarwal; Jan Claassen; E Sander Connolly; Stephan A Mayer
Journal:  Crit Care       Date:  2015-08-31       Impact factor: 9.097

10.  Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage.

Authors:  Sung-Ho Ahn; Jude P J Savarraj; Kaushik Parsha; Georgene W Hergenroeder; Tiffany R Chang; Dong H Kim; Ryan S Kitagawa; Spiros L Blackburn; H Alex Choi
Journal:  J Neuroinflammation       Date:  2019-11-11       Impact factor: 8.322

View more
  2 in total

Review 1.  Melatonin as a Potential Neuroprotectant: Mechanisms in Subarachnoid Hemorrhage-Induced Early Brain Injury.

Authors:  Chengyan Xu; Zixia He; Jiabin Li
Journal:  Front Aging Neurosci       Date:  2022-04-29       Impact factor: 5.702

Review 2.  Biological Effects and Mechanisms of Caspases in Early Brain Injury after Subarachnoid Hemorrhage.

Authors:  Yiwen Wu; Yuchun Liu; Chenhui Zhou; Yuefei Wu; Jie Sun; Xiang Gao; Yi Huang
Journal:  Oxid Med Cell Longev       Date:  2022-07-05       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.